Security key
52635N103
LENZ Therapeutics, Inc. - Common Stock (LENZ)
CUSIP: 52635N103
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 31,105,155
- Total 13F shares
- 24,727,156
- Share change
- +3,653,975
- Total reported value
- $725,109,733
- Put/Call ratio
- 2.7%
- Price per share
- $29.31
- Number of holders
- 113
- Value change
- +$107,969,187
- Number of buys
- 76
- Number of sells
- 31
Report period
Q2 2025
Institutions
113
Top holders
10
LENZ full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
LENZ Therapeutics, Inc. SEC filings
LENZ Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 52635N103
Recent filing periods:
Top shareholders of LENZ - LENZ Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
3/4/5
|
Company · Director, 10%+ Owner |
13%
|
4,178,823
|
$107,437,539 | — | 31 Mar 2025 | |
| Alpha Wave Global, LP |
13F
|
Company |
12%
|
3,612,211
|
$92,869,945 | — | 31 Mar 2025 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
4.9%
|
1,511,932
|
$38,871,772 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.9%
|
1,199,462
|
$30,838,169 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
3.8%
|
1,166,517
|
$29,991,160 | — | 31 Mar 2025 | |
| 72 Investment Holdings, LLC |
13F
|
Company |
3.3%
|
1,017,751
|
$26,166,378 | — | 31 Mar 2025 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
3.1%
|
977,245
|
$25,124,969 | — | 31 Mar 2025 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
2.8%
|
863,389
|
$22,197,731 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
2.7%
|
852,244
|
$21,911,203 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.5%
|
766,940
|
$19,718,027 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
2.1%
|
667,164
|
$17,152,786 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.7%
|
537,738
|
$13,825,244 | — | 31 Mar 2025 | |
| Samsara BioCapital, LLC |
13F
|
Company |
1.7%
|
526,390
|
$13,533,487 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
360,392
|
$9,268,477 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.99%
|
306,978
|
$7,893,000 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.92%
|
287,356
|
$7,387,923 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.61%
|
188,744
|
$4,852,608 | — | 31 Mar 2025 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.57%
|
176,166
|
$4,529,228 | — | 31 Mar 2025 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.46%
|
142,113
|
$3,653,725 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.45%
|
140,954
|
$3,623,927 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.4%
|
124,046
|
$3,189,223 | — | 31 Mar 2025 | |
| SCOGGIN MANAGEMENT LP |
13F
|
Company |
0.32%
|
100,000
|
$2,571,000 | — | 31 Mar 2025 | |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC |
13F
|
Company |
0.27%
|
83,172
|
$2,138,352 | — | 31 Mar 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.27%
|
83,082
|
$2,136,038 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0.26%
|
81,139
|
$2,086,084 | — | 31 Mar 2025 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.25%
|
77,275
|
$1,986,740 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.22%
|
67,037
|
$1,723,522 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.21%
|
66,030
|
$1,697,632 | — | 31 Mar 2025 | |
| Vivaldi Capital Management LP |
13F
|
Company |
0.19%
|
59,252
|
$1,523,369 | — | 31 Mar 2025 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.16%
|
49,622
|
$1,276,000 | — | 31 Mar 2025 | |
| HARBOR CAPITAL ADVISORS, INC. |
13F
|
Company |
0.16%
|
48,616
|
$1,250,000 | — | 31 Mar 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.14%
|
42,230
|
$1,085,733 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.13%
|
41,781
|
$1,074,042 | — | 31 Mar 2025 | |
| BBR PARTNERS, LLC |
13F
|
Company |
0.13%
|
40,000
|
$1,028,400 | — | 31 Mar 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.11%
|
34,828
|
$895,428 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.1%
|
30,488
|
$783,846 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.1%
|
30,405
|
$781,713 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.09%
|
28,694
|
$737,723 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.09%
|
27,935
|
$718,209 | — | 31 Mar 2025 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.09%
|
27,829
|
$715,000 | — | 31 Mar 2025 | |
| Verition Fund Management LLC |
13F
|
Company |
0.09%
|
27,569
|
$708,799 | — | 31 Mar 2025 | |
| KESTRA PRIVATE WEALTH SERVICES, LLC |
13F
|
Company |
0.09%
|
27,304
|
$701,986 | — | 31 Mar 2025 | |
| Lisanti Capital Growth, LLC |
13F
|
Company |
0.08%
|
25,665
|
$659,847 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.08%
|
24,401
|
$627,349 | — | 31 Mar 2025 | |
| Delta Investment Management, LLC |
13F
|
Company |
0.08%
|
24,001
|
$617,066 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.07%
|
22,933
|
$589,607 | — | 31 Mar 2025 | |
| Swiss National Bank |
13F
|
Company |
0.07%
|
21,300
|
$547,623 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.06%
|
18,325
|
$471,136 | — | 31 Mar 2025 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.06%
|
18,000
|
$462,780 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.06%
|
17,967
|
$461,920 | — | 31 Mar 2025 |
Institutional Holders of LENZ Therapeutics, Inc. - Common Stock (LENZ) as of Q2 2025
As of 30 Jun 2025,
LENZ Therapeutics, Inc. - Common Stock (LENZ) was held by
113 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,727,156 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Alpha Wave Global, LP, Paradigm Biocapital Advisors LP, BlackRock, Inc., VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., 72 Investment Holdings, LLC, SECTORAL ASSET MANAGEMENT INC, TANG CAPITAL MANAGEMENT LLC, and UBS Group AG.
This page lists
113
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
105
Q2 2025 holders
113
Holder diff
8
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.